Methotrexate plus sulfasalazine
YK 01-2012
Approved small_molecule terminated
Quick answer
Methotrexate plus sulfasalazine for Rheumatoid Arthritis is a Approved program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Rheumatoid Arthritis
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated